Dow Up 2.00% Nasdaq Up 1.66%

Epizyme, Inc. (EPZM)

-NasdaqGS
9.54 Up 0.64(7.19%) Feb 12, 4:00PM EST
Prev Close:8.90
Open:9.09
Bid:N/A
Ask:10.97 x 100
1y Target Est:32.14
Beta:0.680665
Earnings Date:Mar 10 - Mar 14 (Est.)
Day's Range:8.61 - 9.59
52wk Range:8.27 - 28.48
Volume:330,759
Avg Vol (3m):650,350
Market Cap:525.31M
P/E (ttm):N/A
EPS (ttm):-3.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
EPZMUp 7.19%525.31M
GSKUp 1.56%96.22B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):30.04
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-3.63
Quarterly EPS Est (Dec-15) :-0.65
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops epigenetic therapies for cancer patients. Its proprietary product platform creates small molecule inhibitors of a 96-member class of enzymes known as histone methylt... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback